New Orders Set To Clear Indian Trial Bottlenecks ‘Soon’

India's drugs regulator has indicated that bottlenecks impeding the flow of clinical trial-related activity in the country will be done away with, and that orders pertaining to a host of contentious clauses are likely soon.